Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Inventory (2020 - 2025)

Beauty Health (SKIN) has disclosed Change in Inventory for 6 consecutive years, with -$2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 326.0% to -$2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$8.1 million, a 124.12% decrease, with the full-year FY2024 number at $10.5 million, down 53.57% from a year prior.
  • Change in Inventory was -$2.0 million for Q3 2025 at Beauty Health, up from -$5.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $32.9 million in Q3 2022 to a low of -$11.3 million in Q2 2023.
  • A 5-year average of $6.0 million and a median of $2.3 million in 2021 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 1568.23% in 2022, then plummeted 326.0% in 2025.
  • Beauty Health's Change in Inventory stood at $4.8 million in 2021, then surged by 155.46% to $12.2 million in 2022, then surged by 112.87% to $26.0 million in 2023, then tumbled by 88.36% to $3.0 million in 2024, then tumbled by 166.79% to -$2.0 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Change in Inventory are -$2.0 million (Q3 2025), -$5.3 million (Q2 2025), and -$3.8 million (Q1 2025).